Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, Pravin Dinkar Supe, Inderjeet Godara, Ramesh Revanna, Rajnish Nagarkar, Jayesh Sanmukhani, Ayan Dey, T.M. Chozhavel Rajanathan, Kevinkumar Kansagra, Parshottam Koradia